Trial · NCT06116955
The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy
NCT06116955, Completed, The Affiliated Hospital of Qingdao University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy. Trials, record NCT06116955. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06116955
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy
- NCT number
- NCT06116955
- Status
- Completed
- Enrollment
- 424 participants, actual
- Lead sponsor
- The Affiliated Hospital of Qingdao University
- Conditions
- Bronchoscopy
- Interventions
- Midazolam and sufentanil, Midazolam, sufentanil and propofol, Remazolam and sufentanil., Remazolam, sufentanil and propofol
- First posted
- 2023-11-03
- Last updated
- 2024-01-31
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Patient satisfaction | During bronchoscopy. | The investigator needs to use VAS scores to evaluate satisfaction about sedation feeling when they accepted bronchoscopy. The score from 0 (extremely dissatisfied) to 10 (extremely satisfied). |
| Primary | Clinical satisfaction | During bronchoscopy. | The investigator needs to use VAS scores to evaluate satisfaction about doctors and nurses when they carry out the operation. The score from 0 (extremely dissatisfied) to 10 (extremely satisfied). |
| Primary | Patient's recovery time | The end of bronchoscopy (up to 2 hours). | The investigator needs to record the wake-up time of patients after the end of bronchoscopy. |
| Primary | Patient's departure time | The end of bronchoscopy (up to 2 hours). | The investigator needs to record the patient's departure time after the end of bronchoscopy. |
| Secondary | Induction time | Before bronchoscopy. | Time from administering sedative and analgesic drugs to titration with propofol until MOAA/S 2-3 points. |
| Secondary | Drug dosage | Before bronchoscopy and during bronchoscopy. | Induced, maintenance and total dose of midazolam, propofol. |
| Secondary | Additional frequency of propofol during bronchoscopy | During bronchoscopy. | Additional frequency of propofol during bronchoscopy. |
| Secondary | Additional frequency of 2% lidocaine during bronchoscopy | During bronchoscopy. | Additional frequency of 2% lidocaine during bronchoscopy. |
| Secondary | Additional dosage of 2% lidocaine during bronchoscopy | During bronchoscopy. | Additional dosage of 2% lidocaine during bronchoscopy. |
| Secondary | Additional dosage of propofol during bronchoscopy | During bronchoscopy. | Additional dosage of propofol during bronchoscopy. |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06116955
GET https://conductscience.org/api/trials/v1/NCT06116955/registered